Health Values of Patients Infected with Human Immunodeficiency Virus: Relationship to Mental Health and Physical Functioning

Medical Care

Volumn 34, Issue 1, 1996, Pages 44-57

  Tsevat, Joel ^a   Solzan, Jenny G ^a   Kuntz, Karen M ^a   Ragland, Julia ^a   Currier, Judith S ^a   Sell, Randall L ^a   Weinstein, Milton C ^a  

^a NONE

Author keywords

Health status; Human immunodeficiency virus; Quality of life; Utility assessment

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; DAILY LIFE ACTIVITY; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MENTAL HEALTH; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; UNITED STATES;

ACTIVITIES OF DAILY LIVING; ADULT; ATTITUDE TO HEALTH; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; MALE; MASSACHUSETTS; MENTAL HEALTH; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 0029684773     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199601000-00004     Document Type: Article

References (55)

1. Tsevat J, Weeks JC, Guadagnoli E, et al. Using health-related quality of life information: Clinical encounters, clinical trials, and health policy. J Gen Intern Med 1994;9:576.
2. Patrick DL, Erickson P. Health status and health policy: Quality of life in health care evaluation and resource allocation. New York, NY: Oxford University Press; 1992.
3. Tsevat J. Methods for assessing health-related quality of life in HIV-infected patients. Psychology and Health 1994;9:19.
4. Spilker B, Molinek FR Jr, Johnston KA, Simpson RL Jr, Tilson HH. Quality of life bibliography and indexes. Med Care 1990;28:DS1.
5. Torrance GW. Measurement of health state utilities for economic appraisal: A review. J Health Econ 1986;5:1.
6. Tsevat J, Goldman L, Lamas GA, et al. Functional status versus utilities in survivors of myocardial infarction. Med Care 1991;29:1153.
7. Tsevat J, Goldman L, Soukup JR, et al. Stability of time-tradeoff utilities in survivors of myocardial infarction. Med Decis Making 1993;13:161.
8. Churchill DN, Torrance GW, Taylor DW, et al. Measurement of quality of life in end-stage renal disease: The time trade-off approach. Clin Invest Med 1987;10:14.
9. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 1990;300:573.
10. Revicki DA. Relationship between health utility and psychometric health status measures. Med Care 1992;30:MS274.
11. Llewellyn-Thomas HA, Sutherland HJ, Tritchler DL, et al. Benign and malignant breast disease: The relationship between women's health status and health values. Med Decis Making 1991;11:180.
12. Hornberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patients' well-being and consequent effects on a cost-effectiveness analysis. J Clin Epidemiol 1992;45:505.
13. Tsevat J, Cook EF, Green ML, et al. Health values of the seriously ill. Ann Intern Med 1995;122:514.
14. Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 1993;2:477.
15. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial. N Engl J Med 1987;317:185.
16. Wu AW, Mathews WC, Brysk LT, et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr 1990;3:683.
17. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Med Care 1991;29:786.
18. Ragsdale D, Morrow JR. Quality of life as a function of HIV classification. Nurs Res 1990;39:355.
19. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: Measurement by the Medical Outcomes Study instrument. Ann Intern Med 1992;116:129.
20. Lubeck DP, Fries JF. Health status among persons infected with human immunodeficiency virus: A community-based study. Med Care 1993;31:269.
21. Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992;1:359.
22. Cleary PD, Fowler FJ, Weissman J, et al. Health-related quality of life in persons with acquired immune deficiency syndrome. Med Care 1993;31:569.
23. Williams JBW, Rabkin JG. The concurrent validity of items in the Quality-of-life Index in a cohort of HIV-positive and HIV-negative gay men. Controlled Clin Trials 1991;12:129S.
24. Wu AW, Rubin HR. Approaches to health status assessment in HIV disease: Overview of the conference. Psychology and Health 1994;9:1.
25. Wu AW, Lamping DL. Assessment of quality of life in HIV disease. AIDS 1994;8(suppl 1):S349.
26. Lamping DL. Methods for measuring outcomes to evaluate interventions to improve health-related quality of life in HIV infection. Psychology and Health 1994;9:31.
27. Revicki DA, Wu AW, Murray MI. Change in clinical status, health status and health utility outcomes in HIV-infected patients. Med Care 1995:33(suppl 4):AS173.
28. Lenderking WR, Gelber RD, Cotton DJ, et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. N Engl J Med 1994;330:738.
29. Phillips RS, Goldman L, Bergner M. Patient characteristics in SUPPORT: Activity status and cognitive function. J Clin Epidemiol 1990;43:33S.
30. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990;322:941.
31. Fischl MA, Richman DD, Hansen N, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: A double-blind, placebo-controlled trial. Ann Intern Med 1990;112:727.
32. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Med Care 1992;30:473.
33. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247.
34. McHorney CA, Ware JE Jr., Lu JFR, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40.
35. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85:751.
36. Veit CT, Ware JR Jr. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol 1983;51:730.
37. Weinstein MC, Berwick DM, Goldman PA, Murphy JM, Barsky AJ. A comparison of three psychiatric screening tests using receiver operating characteristic (ROC) analysis. Med Care 1989;27:593.
38. Tsevat J, Dawson NV, Matchar DB. Assessing quality of life and preferences in the seriously ill using utility theory. J Clin Epidemiol 1990;43:73S.
39. Kaplan RM, Bush JW, Berry CC. Health status: Types of validity and the index of well-being. Health Serv Res 1976;11:478.
40. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972;7:118.
41. Cohen J. Statistical power analysis for the behavioral sciences. New York, NY: Academic Press, 1977.
42. STATA Reference Manual. Release 3, 5th ed, Vol 3. Santa Monica, CA: Computing Resource Center, 1992:141.
43. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 health survey: Manual & interpretation guide. Boston, MA: Nimrod Press, 1993.
44. Atkinson JH Jr., Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus: A controlled study. Arch Gen Psychiatry 1988;45:859.
45. Kurdek LA, Siesky G. The nature and correlates of psychological adjustment in gay men with AIDS-related conditions. J Appl Soc Psychol 1990;20:846.
46. Chuang HT, Devins GM, Hunsley J, Gill MJ. Psychological distress and well-being among gay and bisexual men with human immunodeficiency virus infection. Am J Psychiatry. 1989;146:876.
47. Moulton JM, Stempel RR, Bacchetti P, Temoshok L, Moss AR. Results of a one-year longitudinal study of HIV antibody test notification from the San Francisco General Hospital cohort. J Acquir Immune Defic Syndr 1991;4:787.
48. Selwyn PA. AIDS: What is now known. IV: Psychological aspects, treatment prospects. Hosp Pract (Off Ed) 1986;21:125.
49. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam health outcomes study: Initial catalog of health-state quality factors. Med Decis Making 1993;13:89.
50. Fowler JF Jr., Cleary PD, Massagli MP, Weissman J, Epstein A. The role of reluctance to give up life in the measurement of the values of health states. Med Decis Making 1995;15:195.
51. Llewellyn-Thomas HA, Thiel EC, McGreal MJ. Cancer patients' evaluations of their current health states: The influences of expectations, comparisons, actual health status, and mood. Med Decis Making 1992;12:115.
52. Hamilton JD, Hartigan PM, Simberkoff MS, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: Results of the Veterans Affairs Cooperative Study. N Engl J Med 1992;326:437.
53. Furlong W, Feeny D, Torrance GW, Barr R, Horsman J. Guide to design and development of health-state utility instrumentation. Hamilton, Ontario: McMaster University, 1990. Center for Health Economics and Policy Analysis working paper series #90-9.
54. Katz JN, Phillips CB, Fossel AH, Liang MH. Stability and responsiveness of utility measures. Med Care 1994;32:183.
55. Pliskin JS, Shepard DS, Weinstein MC. Utility functions for life years and health status. Oper Res 1980;28:206.